BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Clinical trials for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER explained in plain language.
Never miss a new study
Get alerted when new BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER trials appear
Sign up with your email to follow new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bladder wash treatment aims to spare patients from major surgery
Disease control Not yet recruitingThis study is testing a new bladder wash treatment called NDV-01 for people with early-stage bladder cancer that hasn't spread into the muscle wall. The goal is to see if this treatment can better control the cancer and prevent it from coming back, potentially helping patients av…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Apr 04, 2026 00:36 UTC
-
New bladder cancer treatment trial aims to beat standard chemotherapy
Disease control Not yet recruitingThis study is testing whether a new treatment called TARA-002 works better than standard chemotherapy for adults with high-grade bladder cancer that hasn't spread into the muscle wall. Researchers will give TARA-002 directly into the bladder and compare it to standard chemotherap…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Doctors test virus that targets and kills bladder cancer cells
Disease control Not yet recruitingThis study is testing a new treatment for high-risk bladder cancer that has not spread into the muscle wall. Doctors will put a specially engineered virus directly into the bladder to try to kill cancer cells. The study will enroll about 18 patients to find a safe dose and see if…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New bladder cancer treatment aims to stop recurrence
Disease control Not yet recruitingThis study is testing whether adding a targeted drug called disitamab vedotin to the standard BCG treatment works better for controlling high-risk, early-stage bladder cancer. It will involve about 182 patients whose cancer has been surgically removed but is at high risk of retur…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Doctors test 'Activated' saline to fight bladder tumors
Disease control Not yet recruitingThis early study is testing a new liquid treatment called Plasma-Activated Saline Solution (PASS) for bladder cancer. Five patients scheduled for bladder removal surgery will receive the liquid directly into their bladder over one week. The main goals are to see if the treatment …
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: EARLY_PHASE1 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
A virtual hand to hold: can a family video call calm surgery fears?
Symptom relief Not yet recruitingThis study is testing if a simple video call with a family member can help patients feel less anxious and fearful while waiting for bladder tumor surgery. Researchers will compare patients who have a video call to those who receive standard care, measuring stress and anxiety leve…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: NA • Sponsor: Bitlis Eren University • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC
-
Does age or gender affect pain during a bladder exam? new study investigates
Knowledge-focused Not yet recruitingThis study aims to understand how a patient's age and sex affect the pain they expect and feel during their first flexible cystoscopy, a common outpatient procedure to examine the bladder and urethra. Researchers will enroll 150 adults with no prior scope experience to measure th…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Sponsor: Kayseri Education and Research Hospital • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Mapping surgical scars: new system aims to track hidden injuries in common cancer procedure
Knowledge-focused Not yet recruitingThis study aims to create a better system for tracking and describing injuries that can happen inside the bladder during a common cancer surgery called TURBT. Researchers will observe 1,000 patients to see how often different types of injuries occur and how they are managed. The …
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Sponsor: Necmettin Erbakan University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC